These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4117046)
1. The development of plasma derivatives in Canada. McVicar GA Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046 [No Abstract] [Full Text] [Related]
2. Experiences in the development of plasma derivatives in Japan. Naito R Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047 [No Abstract] [Full Text] [Related]
3. The development of plasma derivatives in Switzerland. Kistler P Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011 [No Abstract] [Full Text] [Related]
4. Development of plasma derivatives for clinical use. Tullis JL Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048 [No Abstract] [Full Text] [Related]
5. Notes on the development of plasma derivatives in the Netherlands. Krijnen HW Vox Sang; 1972; 23(1):32. PubMed ID: 5081012 [No Abstract] [Full Text] [Related]
6. The current status of blood fractionation in the United States. Sgouris JT Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014 [No Abstract] [Full Text] [Related]
7. Notes on the production of plasma derivatives in France. Steinbuch M Vox Sang; 1972; 23(1):56-7. PubMed ID: 4117049 [No Abstract] [Full Text] [Related]
8. The development of plasma derivatives for clinical use. A symposium summary. Deutsch HF Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010 [No Abstract] [Full Text] [Related]
9. Plasma fractionation in England and Wales. Vallet L Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157 [No Abstract] [Full Text] [Related]
10. Precipitation methods in plasma fractionation. Steinbuch M Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018 [No Abstract] [Full Text] [Related]
11. Plasma fractionation in the United States. A review for clinicians. Ness PM; Pennington RM JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885 [No Abstract] [Full Text] [Related]
12. Notes on plasma derivative production in the Federal Republic of Germany. Schwick HG Vox Sang; 1972; 23(1):44. PubMed ID: 5081013 [No Abstract] [Full Text] [Related]
13. The development of plasma derivatives in Australia. Schiff P Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156 [No Abstract] [Full Text] [Related]
14. Transmission of viral hepatitis, type B, by plasma derivatives. Barker LF; Hoofnagle JH Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771 [No Abstract] [Full Text] [Related]
16. Prevalence of HB Ag and HB Ab in the Canadian blood-donor population. Moore BP Haematologia (Budap); 1974; 8(1-4):409-13. PubMed ID: 4461428 [No Abstract] [Full Text] [Related]
17. Plasma fractionation methods used in Sweden. Björling H Vox Sang; 1972; 23(1):18-25. PubMed ID: 4628155 [No Abstract] [Full Text] [Related]
18. [Search for the Australia antigen and the corresponding antibody in blood transfusion]. Soulier JP Presse Med (1893); 1970 Feb; 78(11):485-6. PubMed ID: 4190680 [No Abstract] [Full Text] [Related]
19. [Prevention of transmission of viral hepatitis by blood derivatives by regular screening for Australia antigen (Au-HAA)]. Novák J; Urbánková J Cas Lek Cesk; 1972; 111(18):409-12. PubMed ID: 5023513 [No Abstract] [Full Text] [Related]
20. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations. Tozer RA P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]